Quick Facts
| CAS Number | 21462-39-5 (HCl) / 24729-96-2 (Phosphate) |
|---|---|
| Molecular Formula | C18H33ClN2O5S · HCl (HCl) / C18H34ClN2O8PS (Phosphate) |
| Molecular Weight | 461.44 (HCl) / 504.96 (Phosphate) |
| Pharmacopoeia | BP/USP/CEP/EP/CPV |
| Packaging | 25 KG/DRUM |
USP Standard
EP/BP Standard
GMP Certified
Product Overview
Clindamycin HCl/Phosphate is a lincosamide antibiotic phosphate ester and a semi-synthetic derivative of lincomycin. It has superior oral absorption and broader activity compared to its parent compound, effective against most Gram-positive bacteria and anaerobes in human medicine.
Clindamycin inhibits bacterial protein synthesis at the 50S ribosomal subunit. Clindamycin Phosphate is a water-soluble prodrug for parenteral (IV/IM) and topical formulations. It is rapidly hydrolyzed in vivo to active clindamycin. It achieves excellent tissue and abscess penetration.
Quality Specifications
| Purity | As per USP monograph |
|---|---|
| Residual Solvents | Compliant with ICH Q3C |
| Heavy Metals | Compliant with pharmacopoeia limits |
| GMP Status | Manufactured under GMP conditions |
Pharmaceutical Applications
- Anaerobic infections: Intra-abdominal and pelvic anaerobic infections
- Skin and soft tissue infections: Cellulitis, abscesses, and wound infections
- Bacterial vaginosis: Topical and oral formulations
- Acne vulgaris: Topical formulations for moderate to severe acne
- Surgical prophylaxis: Alternative in penicillin-allergic patients
Standards: BP/USP/CEP/EP/CPV | CAS: 21462-39-5 (HCl) / 24729-96-2 (Phosphate) | Quality data verified against pharmacopoeia monograph
COA and MSDS available | DrugBank | June 2026